Freestone Grove Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,480
Closed -$51.5K 758
2025
Q1
$51.5K Buy
+15,480
New +$51.5K ﹤0.01% 568